The optimal dose of triptorelin for triggering final oocyte maturation in patients at high-risk for OHSS: a randomized clinical trial

被引：0
|
作者：
Lainas, G. T. [1 ]
Bosdou, J. K. [1 ]
Venetis, C. A. [2 ]
Sfontouris, I. A. [3 ]
Chatzimeletiou, K. [1 ]
Zepiridis, L. [1 ]
Makedos, A. [1 ]
Daniilidis, A. [1 ]
Mitsoli, A. [1 ]
Savvaidou, D. [1 ]
Lainas, T. G. [3 ]
Tarlatzis, B. C. [1 ]
Kolibianakis, E. M. [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Sch Med, Unit Human Reprod, Dept Obstet & Gynecol 1, GR-54006 Thessaloniki, Greece
[2] Univ New S Wales, Sch Womens & Childrens Hlth UNSW Med, Sydney, NSW, Australia
[3] EUGONIA, Eugonia Unit Assisted Reprod, Athens, Greece
来源：
HUMAN REPRODUCTION | 2015年 / 30卷
关键词：
agonist trigger; triptorelin dose; high risk for OHSS; oocyte maturity; OHSS prevention;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-219
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [31] Topical tacrolimus for high-risk corneal transplantation: a randomized, clinical trial
    Shimazaki, Jun
    Tomida, Daisuke
    Yagi-Yaguchi, Yukari
    Satake, Yoshiyuki
    Yamaguchi, Takefumi
    BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [32] High-Risk Medications in Persons Living With Dementia: A Randomized Clinical Trial
    Singh, Sonal
    Li, Xiaojuan
    Cocoros, Noelle M.
    Antonelli, Mary T.
    Avula, Ramya
    Crawford, Sybil L.
    Dashevsky, Inna
    Fouayzi, Hassan
    Harkins, Thomas P.
    Mazor, Kathleen M.
    Michnick, Ashley I.
    Parlett, Lauren
    Paullin, Mark
    Platt, Richard
    Rochon, Paula A.
    Saphirak, Cassandra
    Si, Mia
    Zhou, Yunping
    Gurwitz, Jerry H.
    JAMA INTERNAL MEDICINE, 2024, 184 (12) : 1426 - 1433
  • [33] Will the hCG trigger dose used for final oocyte maturation in IVF impact endogenous progesterone during the luteal phase? - A randomized controlled trial
    Svenstrup, L.
    Fedder, J.
    Moller, S.
    Pedersen, D.
    Erb, K.
    Andersen, C. Ydin
    Humaidan, P.
    HUMAN REPRODUCTION, 2021, 36 : 446 - 446
  • [34] Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting
    DiLuigi, Andrea J.
    Engmann, Lawrence
    Schmidt, David W.
    Maier, Donald B.
    Nulsen, John C.
    Benadiva, Claudio A.
    FERTILITY AND STERILITY, 2010, 94 (03) : 1111 - 1114
  • [35] A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
    Kim, Jin Yong
    Sandulescu, Oana
    Preotescu, Liliana-Lucia
    Rivera-Martinez, Norma E.
    Dobryanska, Marta
    Birlutiu, Victoria
    Miftode, Egidia G.
    Gaibu, Natalia
    Caliman-Sturdza, Olga
    Florescu, Simin-Aysel
    Shi, Hye Jin
    Streinu-Cercel, Anca
    Streinu-Cercel, Adrian
    Lee, Sang Joon
    Kim, Sung Hyun
    Chang, Ilsung
    Bae, Yun Ju
    Suh, Jee Hye
    Chung, Da Rae
    Kim, Sun Jung
    Kim, Mi Rim
    Lee, Seul Gi
    Park, Gahee
    Eom, Joong Sik
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (08):
  • [36] A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial
    Abbara, Ali
    Clarke, Sophie
    Islam, Rumana
    Prague, Julia K.
    Comninos, Alexander N.
    Narayanaswamy, Shakunthala
    Papadopoulou, Deborah
    Roberts, Rachel
    Izzi-Engbeaya, Chioma
    Ratnasabapathy, Risheka
    Nesbitt, Alexander
    Vimalesvaran, Sunitha
    Salim, Rehan
    Lavery, Stuart A.
    Bloom, Stephen R.
    Huson, Les
    Trew, Geoffrey H.
    Dhillo, Waljit S.
    HUMAN REPRODUCTION, 2017, 32 (09) : 1915 - 1924
  • [37] Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients
    Haase, Michael
    Haase-Fielitz, Anja
    Bagshaw, Sean M.
    Reade, Michael C.
    Morgera, Stanislao
    Seevenayagam, Siven
    Matalanis, George
    Buxton, Brian
    Doolan, Laurie
    Bellomo, Rinaldo
    CRITICAL CARE MEDICINE, 2007, 35 (05) : 1324 - 1331
  • [38] Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease A Randomized Clinical Trial
    Vardeny, Orly
    Kim, KyungMann
    Udell, Jacob A.
    Joseph, Jacob
    Desai, Akshay S.
    Farkouh, Michael E.
    Hegde, Sheila M.
    Hernandez, Adrian F.
    McGeer, Allison
    Talbot, H. Keipp
    Anand, Inder
    Bhatt, Deepak L.
    Cannon, Christopher P.
    DeMets, David
    Gaziano, J. Michael
    Goodman, Shaun G.
    Nichol, Kristin
    Tattersall, Matthew C.
    Temte, Jonathan L.
    Wittes, Janet
    Yancy, Clyde
    Claggett, Brian
    Chen, Yi
    Mao, Lu
    Havighurst, Thomas C.
    Cooper, Lawton S.
    Solomon, Scott D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (01): : 39 - 49
  • [39] Effects of health counseling on high-risk cardiology outpatient clinical trial behavioural risk factors in a population: a randomized clinical trial
    Harting, Janneke
    Van Assema, Patricia
    Van Limpt, Patrick
    Gorgels, Ton
    Van Ree, Jan
    Ruland, Erik
    Vermeer, Frank
    De Vries, Nanne K.
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2006, 13 (02): : 214 - 221
  • [40] Dose-intensified versus standard chemotherapy in high-risk breast cancer patients: Preliminary data of a randomized trial
    Thomssen, C
    Untch, M
    Schill, E
    Sattler, D
    Konecny, G
    Bauernfeind, P
    Janicke, F
    Graeff, H
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 662 - 662
12345